Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti‐HIV microbicide

Abstract

The in vitro efficacy of GRFT revealed low cytotoxicity, high potency, rapid onset of antiviral activity and long-term stability in cervical/vaginal lavage. GRFT is an excellent candidate for anti-HIV microbicide development.